Genomic Effects of Glucocorticoids in SLE

Phase 1, randomised, open-label trial of methylprednisolone injection in systemic lupus erythematosus (SLE) (2 arms), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Primary endpoints: Differential Gene Expression at 4 hours and Number of SLE Patients That Were Sampled for RNA-seq Differential Expression Analysis at 4 hours. Started Mar 2020; status: completed.